Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Qiagen (QGEN) Operating Expenses (2016 - 2026)

Qiagen's Operating Expenses history spans 18 years, with the latest figure at $51.2 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 73.51% to $51.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $691.5 million, a 20.23% decrease, with the full-year FY2025 number at $833.6 million, down 4.14% from a year prior.
  • Operating Expenses hit $51.2 million in Q1 2026 for Qiagen, down from $225.8 million in the prior quarter.
  • Over the last five years, Operating Expenses for QGEN hit a ceiling of $263.2 million in Q2 2024 and a floor of $50.3 million in Q3 2022.
  • Historically, Operating Expenses has averaged $191.7 million across 5 years, with a median of $206.7 million in 2023.
  • Biggest five-year swings in Operating Expenses: soared 299.03% in 2023 and later plummeted 73.51% in 2026.
  • Tracing QGEN's Operating Expenses over 5 years: stood at $213.0 million in 2022, then fell by 3.51% to $205.5 million in 2023, then increased by 4.24% to $214.2 million in 2024, then grew by 5.43% to $225.8 million in 2025, then crashed by 77.32% to $51.2 million in 2026.
  • Business Quant data shows Operating Expenses for QGEN at $51.2 million in Q1 2026, $225.8 million in Q4 2025, and $202.1 million in Q3 2025.